Alexza Pharmaceutica (ALXA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,923 | -21,511 | -20,712 | -27,978 | -17,705 |
| Depreciation Amortization | 3,271 | 1,845 | 930 | 4,784 | 3,818 |
| Accounts receivable | -25 | -106 | 0 | 10,000 | 10,000 |
| Accounts payable and accrued liabilities | 1,920 | 1,239 | 1,210 | -1,456 | -1,771 |
| Other Working Capital | -2,996 | -4,223 | -890 | 2,267 | 1,834 |
| Other Operating Activity | 41,802 | 42,770 | 10,349 | -5,858 | -7,162 |
| Operating Cash Flow | $10,049 | $20,014 | $-9,113 | $-18,241 | $-10,986 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -8,642 | -9,143 | 0 | 2,000 | 2,000 |
| PPE Investments | -1,472 | -890 | -313 | -27 | 211 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 200 |
| Investing Cash Flow | $-10,114 | $-10,033 | $-313 | $1,973 | $2,411 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,000 | 0 | N/A | N/A | 0 |
| Debt Repayment | -5,027 | -3,308 | -1,633 | -6,110 | -4,520 |
| Common Stock Issued | 6,446 | 6,414 | 0 | 35,242 | 35,177 |
| Other Financing Activity | -5,262 | -4,949 | 5,051 | -10,051 | -11,469 |
| Financing Cash Flow | $6,157 | $-1,843 | $3,418 | $19,081 | $19,188 |
| Beginning Cash Position | 17,715 | 17,715 | 17,715 | 14,902 | 14,902 |
| End Cash Position | 23,807 | 25,853 | 11,707 | 17,715 | 25,515 |
| Net Cash Flow | $6,092 | $8,138 | $-6,008 | $2,813 | $10,613 |
| Free Cash Flow | |||||
| Operating Cash Flow | 10,049 | 20,014 | -9,113 | -18,241 | -10,986 |
| Capital Expenditure | -1,488 | -906 | -313 | -452 | -214 |
| Free Cash Flow | 8,561 | 19,108 | -9,426 | -18,693 | -11,200 |